The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer-Reference-Cited by-同舟云学术

The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer

Published:2018-12 Issue: Volume:108 Page:1415-1424
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Masjedi Ali^ORCID,Hashemi Vida,Hojjat-Farsangi Mohammad^ORCID,Ghalamfarsa Ghasem,Azizi Gholamreza^ORCID,Yousefi Mehdi,Jadidi-Niaragh Farhad^ORCID

Funder

National Institute for Medical Research Development

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference136 articles.

1. Breast cancer;Harbeck;Lancet,2017

2. Triple-negative breast cancer;Foulkes;N. Engl. J. Med.,2010

3. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice;Jadidi-Niaragh;J. Control. Release,2017

4. Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles;Jadidi-Niaragh;Tumor Biol.,2016

5. Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer, Cancer immunology;Kheshtchin;Immunotherapy,2016

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipopolysaccharide-Educated Cancer-Associated Fibroblasts Facilitate Malignant Progression of Ovarian Cancer Cells via the NF-kB/IL-6/JAK2 Signal Transduction;Molecular Biotechnology;2024-02-02

3. A DNA-polymer hybrid nanocomplex based bi-adjuvant vaccine for tumor immunotherapy;Nano Today;2024-02

4. Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC;Cancer Letters;2024-02

5. Polymer lipid hybrid nanoparticles encapsulated with Emodin combined with DOX reverse multidrug resistance of breast cancer via IL-6/JAK2/STAT3 signaling pathway;Cancer Nanotechnology;2024-01-31